Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells

mRNA has recently been established as a new class of therapeutics, due to its programmability and ability to produce proteins of interest rapidly in vivo. Despite its demonstrated utility, mRNA as a protein expression platform remains limited by its translational capacity and RNA stability. Here, we introduce messenger-oligonucleotide conjugated RNAs (mocRNAs) to enable site-specific, robust, and modularized encoding of chemical modifications for highly efficient and stable protein expression. In mocRNA constructs, chemically synthesized oligonucleotides are ligated to the 3 ' terminus of mRNA substrates to protect poly(A) tails from degradation, without compromising their potency in stimulating translation. As a proof-of-concept, mocRNAs modified by deadenylase-resistant oligonucleotides result in augmented protein production by factors of 2-4 in human HeLa cells and by 10-fold in primary rat cortical neuronal cultures. By directly linking enzymatic and organic synthesis of mRNA, we envision that the mocRNA design will open new avenues to expand the chemical space and translational capacity of RNA-based vectors in basic research and therapeutic applications.

Automated summary

mRNA has limitations in terms of translational capacity and RNA stability. This study introduces messenger-oligonucleotide conjugated RNAs (mocRNAs) as a method to enhance protein expression by incorporating chemical modifications. The results show significant increases in protein production using this approach. The mocRNA design opens up new possibilities for RNA-based vectors in research and therapeutics.